Avanos Medical Inc.

NYSE: AVNS · Real-Time Price · USD
11.06
0.10 (0.91%)
At close: Aug 15, 2025, 12:19 PM

Avanos Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
692.5M 689.2M 687.8M 681.5M 682.4M 680.1M 705.7M 749.9M 780.7M 814.3M 820M 795.9M 777.9M 761.3M 744.6M 736.2M 737.8M 715.1M
Cost of Revenue
319.7M 312.9M 306.5M 300.8M 299.1M 294.6M 310.5M 335.2M 351.4M 367.9M 370.9M 366.8M 368.5M 381.1M 380.3M 379.9M 376.1M 352.6M
Gross Profit
372.8M 376.3M 381.3M 380.7M 383.3M 385.5M 395.2M 414.7M 429.3M 446.4M 449.1M 429.1M 409.4M 380.2M 364.3M 356.3M 361.7M 362.5M
Operating Income
-470.7M -380.1M -383M 57.7M 46.9M 28.7M 23.9M 27.9M 45.4M 66.5M 73.1M 71.9M 56.8M 30.5M 8.9M -60.9M -64.6M -59.1M
Interest Income
3.6M 6M 5.1M 5.3M 5.5M 3M 2.9M 2.6M 2M 1.7M 1.2M 500K 400K 200K 200K 300K 300K 500K
Pretax Income
-477.2M -395.1M -403.3M 26.1M 14M 2.7M 800K 15.8M 34.4M 56M 64.3M 64.7M 51.6M 26.9M 5.8M -65.9M -73M -70.7M
Net Income
-463.2M -384.6M -392.1M 15.7M 7.7M -62.2M -61.8M -55.4M -36M 43.5M 49.8M 42.9M -7.9M 18.6M 5.2M -52M 2.4M -38.5M
Selling & General & Admin
305.4M 302.9M 307.6M 296.3M 300.7M 320.5M 332.8M 347M 350.4M 344.5M 341.9M 334.5M 327.4M 317M 300.3M 307.3M 314.7M 314.9M
Research & Development
24.1M 24.6M 26.2M 27.3M 26.2M 26.7M 27.6M 28.3M 29.5M 30.7M 30.6M 30.7M 31.8M 31.8M 32.3M 34.3M 34.1M 33.8M
Other Expenses
431.1M 431.1M 431.1M n/a n/a n/a 1.3M 1.9M 3.9M 4.7M 3.5M -8M -6.6M 900K 22.8M 75.6M 77.5M 72.9M
Operating Expenses
758.4M 756.4M 764.3M 323M 336.4M 356.8M 371.3M 386.8M 383.9M 379.9M 376M 357.2M 352.6M 349.7M 355.4M 417.2M 426.3M 421.6M
Interest Expense
1.9M 11.2M 12.2M 12.7M 14.2M 14.6M 15M 14.7M 13M 12.2M 10M 7.7M 5.6M 3.8M 3.3M 5.3M 8.7M 12.1M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -8.9M -8.9M -8.9M
Cost & Expenses
1.07B 1.06B 1.07B 619.1M 635.5M 651.4M 681.8M 722M 735.3M 747.8M 746.9M 724M 721.1M 730.8M 735.7M 797.1M 802.4M 774.2M
Income Tax Expense
-23.9M -14.9M -17M 4.4M 7M 4.3M 3.4M 12.5M 6.6M 12.5M 14.5M 21.8M 59.5M 8.3M 600K -13.9M -75.4M -32.2M
Shares Outstanding (Basic)
46.1M 46.1M 46M 46M 45.9M 46.2M 46.2M 46.8M 46.8M 46.6M 46.5M 46.6M 47.2M 47.4M 48.2M 48.1M 48.1M 47.5M
Shares Outstanding (Diluted)
46.8M 46.8M 46M 46.6M 46.3M 46.2M 46.6M 46.8M 46.8M 46.6M 47M 47M 47.6M 47.8M 48.6M 48.1M 48.6M 48M
EPS (Basic)
-8.55 -8.37 -8.53 0.34 0.17 -1.33 -1.32 -1.19 -0.77 0.93 1.06 0.91 -0.16 0.39 0.11 -1.09 0.04 -0.81
EPS (Diluted)
-8.55 -8.37 -8.53 0.34 0.17 -1.33 -1.32 -1.19 -0.78 0.92 1.05 0.90 -0.16 0.38 0.10 -1.1 0.03 -0.81
EBITDA
-440.9M -337.8M -340.3M 96.6M 85.3M 71.7M 58.8M 68.8M 80.3M 93.6M 107.9M 102.1M 93.8M 73.3M 50.3M -18.1M -23.6M -16.6M
EBIT
-393.2M -381.5M -385.8M 50.7M 40.1M 26.8M 13.2M 21.3M 32.3M 44.2M 58.9M 57M 47.5M 29.9M 8.9M -60.8M -64.3M -58.6M
Depreciation & Amortization
42.4M 43.7M 45.5M 45.9M 45.2M 44.2M 44.9M 46.8M 47.4M 48.7M 47.7M 43.8M 41.8M 39.7M 38.3M 39.6M 40.7M 42M